Curative effect observation of ambroxol hydrochloride prevent respiratory distress syndrome in premature infants
-
摘要:
目的 分析研究盐酸氨溴索预防早产儿呼吸窘迫综合征(NRDS)的临床效果。 方 法选择2012年4月~2013年4月我院收治的62例早产儿,随机分为观察组39例和对照组23例,观察组在常规治疗基础上加用盐酸氨溴索,对照组仅给予常规治疗。观察两组氧分压变化,NRDS发生率,呼吸机机械通气率,氧疗时间,住院时间等情况。 结果观察组新生儿呼吸窘迫综合征发生率明显低于对照组(P<0.05),治疗后观察组氧合改善时间、机械通气率、住院时间均低于对照组(P<0.05)。 结论盐酸氨溴索能较好地防治早产儿呼吸窘迫综合征,改善肺氧合,缩短住院时间,值得在临床上应用。 Abstract:ObjectiveTo discuss the clinical effect of ambroxol in premature children with respiratory distress syndrome (NRDS). Methods The clinical data of 62 premature children in our hospital during April 2012 and April 2013 were collected, and they were randomly divided into observation group (39 cases) and control group (23 cases). The control group were treated with conventional treatment,the observation group were treated with ambroxol on the basis of conventional treatment, Observed the oxygen partial pressure, incidence of RDS, mechanical ventilation rate, duration of mechanical ventilation, oxygen therapy time and length of stay of two groups. ResultsIn the observation group, neonatal respiratory distress syndrome was significantly lower than that in the control group (P<0.05). The oxygen therapy time ,mechanical ventilation rate and length of stay of observation group were shorter than that of the control group, the difference were statistically significant (P<0.05). ConclusionAmbroxol in premature children NRDS has a good effect, simple, convenient, and is worthy of clinical application. -
Key words:
- ambroxol /
- prevent /
- premature children /
- respiratory distress syndrome
-
表 1 两组NRDS发生率比较
组别 n NRDS发生例数 NRDS发生率(%) 观察组 39 3 7.69* 对照组 23 5 21.74 与对照组比较, *P<0.05. 表 2 两组其他指标比较
-
[1] 周登余, 李帅. 氨溴索PS 及联合nCPAP 预防早产儿呼吸窘迫综合征的疗效比较[J]. 安徽医学, 2012, 33(8): 1003-6. http://www.cnki.com.cn/Article/CJFDTOTAL-AHYX201208021.htm [2] 黄壁璇, 张素玲, 徐桂萍, 等. 沐舒坦预防早产儿肺透明膜病40例疗效观察[J]. 现代医药卫生, 2007, 23(6): 815. http://www.cnki.com.cn/Article/CJFDTOTAL-XYWS200706016.htm [3] 李璧瑜, 吕海燕. 盐酸氨溴索预防早产儿呼吸窘迫综合征100例临床分析[J]. 齐齐哈尔医学院学报, 2008, 29(19): 2313-4. http://www.cnki.com.cn/Article/CJFDTOTAL-QQHB200819007.htm [4] 王远明. 氨溴索防治早产儿呼吸窘迫综合征的疗效观察[J]. 临床合理用药杂志, 2011, 4(1A): 10-1. http://www.cnki.com.cn/Article/CJFDTOTAL-PLHY201101009.htm [5] 石宏. 盐酸氨溴索序贯治疗重度婴幼儿肺炎[J]. 实用儿科临床杂志, 2005, 20(4): 361-2. http://www.cnki.com.cn/Article/CJFDTOTAL-SYQK200504045.htm [6] 陈皆兵, 张慧霞. 盐酸氨溴索治疗早产儿肺透明膜病的疗效[J]. 中国现代医生, 2008, 46(3): 94. http://www.cnki.com.cn/Article/CJFDTOTAL-SYQK200602026.htm [7] Gillissen A, Bartling A, Scboen S, et al. Antioxdant function of ambroxol in mononuclcar and polymorphonuclear cells in vitro[J]. Lung, 1997, 175(4): 235-42. doi: 10.1007/PL00007570 [8] 饶红萍, 周玉祥, 陈秋如, 等. 盐酸氨溴索和肺表面活性物质在防治新生呼吸窘迫综合症中的疗效分析[J]. 中国医药导报, 2010, 7(25): 53- 4. http://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201025036.htm [9] 林广浴, 曾虹, 尹君, 等. 生后不同时间应用氨溴索预防早产儿 NRDS的临床观察[J]. 中华急症医学杂志, 2003, 12: 252.
点击查看大图
表(2)
计量
- 文章访问数: 546
- HTML全文浏览量: 236
- PDF下载量: 3
- 被引次数: 0